NDC 68151-2584

Zantac 75

Ranitidine

Zantac 75 is a Oral Tablet, Coated in the Human Otc Drug category. It is labeled and distributed by Carilion Materials Management. The primary component is Ranitidine Hydrochloride.

Product ID68151-2584_18b916c5-b24f-4855-96f3-881e43be87c5
NDC68151-2584
Product TypeHuman Otc Drug
Proprietary NameZantac 75
Generic NameRanitidine
Dosage FormTablet, Coated
Route of AdministrationORAL
Marketing Start Date2006-12-21
Marketing CategoryNDA / NDA
Application NumberNDA020520
Labeler NameCarilion Materials Management
Substance NameRANITIDINE HYDROCHLORIDE
Active Ingredient Strength75 mg/1
NDC Exclude FlagE
Listing Certified Through2018-12-31

Packaging

NDC 68151-2584-0

1 TABLET, COATED in 1 PACKAGE (68151-2584-0)
Marketing Start Date2006-12-21
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 68151-2584-0 [68151258400]

Zantac 75 TABLET, COATED
Marketing CategoryNDA
Application NumberNDA020520
Product TypeHUMAN OTC DRUG
Marketing Start Date2006-12-21
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
RANITIDINE HYDROCHLORIDE75 mg/1

OpenFDA Data

SPL SET ID:6b52d3b3-aca0-450e-985c-0a062d4ab5c2
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 312773
  • 827183

    • NDC Crossover Matching brand name "Zantac 75" or generic name "Ranitidine"

    NDCBrand NameGeneric Name
    0597-0122Zantac 75ranitidine
    67751-152Zantac 75Zantac 75
    68151-2584Zantac 75Zantac 75
    50269-222Zantac 75Zantac 75
    10202-8527 Select Acid ReducerRanitidine
    0904-6350Acid ReducerRanitidine
    0113-7950basic care acid reducerRanitidine
    0113-7852basic care acid reducer 150Ranitidine
    0113-7876basic care acid reducer 75Ranitidine
    0113-0852Good Sense Acid ReducerRanitidine
    0113-0876Good Sense Acid ReducerRanitidine
    10202-712MAXIMUM STRENGTH RANITIDINERanitidine
    0597-0121Maximum Strength Zantacranitidine
    0121-0727RanitidineRANITIDINE
    0121-4727RanitidineRANITIDINE
    0172-4357RanitidineRanitidine
    0172-4358RanitidineRanitidine
    0363-0352RanitidineRanitidine
    0440-8300RanitidineRanitidine
    0440-8305RanitidineRanitidine
    0615-4513RanitidineRanitidine
    0615-4514RanitidineRanitidine
    0615-8021RanitidineRanitidine
    0781-6087RanitidineRanitidine
    0904-6349RanitidineRanitidine
    0904-6716RanitidineRanitidine
    0904-6921RanitidineRanitidine
    10544-056RanitidineRanitidine
    10544-438RanitidineRanitidine
    10544-516RanitidineRanitidine
    11673-849RanitidineRanitidine
    0904-6715ranitidine 75Ranitidine
    11673-023up and up ranitidineRanitidine
    0363-0852wal zan 150Ranitidine
    0363-0950wal zan 150Ranitidine
    0363-1876wal zan 75Ranitidine
    0363-0362Wal-ZanRanitidine
    0597-0120Zantac Maximum Strength 150 Cool Mintranitidine

    Trademark Results [Zantac 75]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    ZANTAC 75
    ZANTAC 75
    77065456 not registered Dead/Abandoned
    Boehringer Ingelheim Pharmaceuticals, Inc
    2006-12-15
    ZANTAC 75
    ZANTAC 75
    74559569 2016139 Live/Registered
    CHATTEM, INC.
    1994-08-09
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.